5C56.0Y

ICD-11 MMS 2026-01

Other specified sphingolipidosis

Exclusions from above levels

5C51.3 – Glycogen storage disease due to LAMP-2 deficiency
http://id.who.int/icd/entity/1191191920 – Disorders of lipoprotein metabolism or certain specified lipidaemias
3A10.Z – Hereditary haemolytic anaemia due to enzyme deficiency

Show allHide

5A71.01 – Congenital adrenal hyperplasia
5A81.1 – 5-alpha-reductase deficiency
LD28.01 – Marfan syndrome
LD28.1 – Ehlers-Danlos syndrome
LD2A.4 – androgen resistance syndrome
18 – Pregnancy, childbirth or the puerperium
http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Sibling codes

5C56.00 – Gangliosidosis
5C56.01 – Fabry disease
5C56.02 – Metachromatic leukodystrophy
5C56.0Z – Sphingolipidosis, unspecified

Foundation entity

Sphingolipidosis – http://id.who.int/icd/entity/1875237176

Part of: 5C56.0: Sphingolipidosis › 5C56: Lysosomal diseases › 05: Endocrine, nutritional or metabolic diseases